With the analysis among 1,528 patents, we discovered top 367 key players by total patent application. Pierre Fabre Médicament SAS, Chugai Pharmaceutical Co., Ltd., Amgen, Inc. are dominant in this area. They take 13.81% of the total patent filing.
Pierre Fabre Médicament SAS
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 70
California, United States
Patent: 51
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 45
F. Hoffmann-La Roche Ltd.
Emergent Product Development Seattle
Washington, United States
Patent: 31
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 29
Tokyo-to, Japan
Patent: 28
Hanmi Pharmaceutical Co., Ltd.
With the analysis among 38 patents, we discovered top 8 start-ups by total patent application. Hrain Biotechnology Co. Ltd., Juventas Cell Therapy Ltd., Beijing Immunochina Pharmaceuticals Co., Ltd. are active in this area.
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 29
Juventas Cell Therapy Ltd.
Tianjin Shi, China
Patent: 2
Beijing Immunochina Pharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 2
Institut National de la Santé et de la Recherche Médicale
Xi'an Yufan Biotechnologies Co., Ltd.
Shaanxi Sheng, China
Patent: 1
Alabama, United States
Patent: 1
MingMed Biotechnology Co. Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 195 patents applied in the last 5 years. We discover 89 most active companies in this area. The fast-growing Amgen, Inc., Hrain Biotechnology Co. Ltd., Shanghai Cell Therapy Group Co. Ltd. take 17.44% of patent filing during this period.
California, United States
Patent: 15
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 10
Shanghai Cell Therapy Group Co. Ltd.
Shanghai Shi, China
Patent: 9
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
Shanghai Cell Therapy Research Institute
undefined undefined
Patent: 9
Chongqing Precision Biotech Co., Ltd
Chongqing Shi, China
Patent: 7
Chugai Pharmaceutical Co., Ltd.
Utrecht, Netherlands
Patent: 6
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 5
Guangdong Sheng, China
Patent: 5
With the analysis among related 195 patents in last 5 years, we discover 50 new entrants. Merus NV, Xi'an Jiaotong University, Erbe Elektromedizin GmbH are the most active new entrants in this area.
Utrecht, Netherlands
Patent: 6
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 5
Baden-Württemberg, Germany
Patent: 3
Liverpool School of Tropical Medicine
CITY OF LIVERPOOL, United Kingdom
Patent: 3
Beijing Marion Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
Microsoft Technology Licensing LLC
Washington, United States
Patent: 2
Baili Sikang Biomedicine (Hangzhou) Co Ltd
Zhejiang Sheng, China
Patent: 2
WuXi Biologics Ireland Ltd.
iCell Gene Therapeutics, Inc.
New York, United States
Patent: 2
Guangdong Sheng, China
Patent: 2
With the analysis among 190 patents, we discovered top 33 universities and scientific research institutions by total patent application. Duke University, Swiss Federal Institute of Technology Zurich, Vanderbilt University are dominant in this area. They take 26.32% of the total patent filing.
North Carolina, United States
Patent: 7
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 7
Tennessee, United States
Patent: 6
Miyagi-ken, Japan
Patent: 6
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 6
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 5
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 5
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 4